An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
Efficacy and Safety of Azvudine in the Treatment of Patients With Corona Virus Disease (COVID-19) Pneumonia in China: an Multi-center Observational, Ambispective Cohort, Real-world Study
Sponsor: Qianfoshan Hospital
Listed as NCT05621993, this observational or N/A phase trial focuses on COVID-19 Respiratory Infection and remains ongoing. Sponsored by Qianfoshan Hospital, it has been updated 6 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Nov 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — Nov 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2022 — Apr 2023 [monthly]
Not Yet Recruiting
First recorded
Nov 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Qianfoshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .